- Home
- IBRX vs VITL Comparison
IBRX vs VITL Comparison
Compare IBRX & VITL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IBRX
- VITL
- Stock Information
- Founded
- IBRX 2014
- VITL 2007
- Country
- IBRX United States
- VITL United States
- Employees
- IBRX N/A
- VITL N/A
- Industry
- IBRX Biotechnology: Biological Products (No Diagnostic Substances)
- VITL Packaged Foods
- Sector
- IBRX Health Care
- VITL Consumer Staples
- Exchange
- IBRX Nasdaq
- VITL Nasdaq
- Market Cap
- IBRX 1.9B
- VITL 1.7B
- IPO Year
- IBRX N/A
- VITL 2020
- Fundamental
- Price
- IBRX $2.94
- VITL $45.01
- Analyst Decision
- IBRX Strong Buy
- VITL Strong Buy
- Analyst Count
- IBRX 3
- VITL 8
- Target Price
- IBRX $13.58
- VITL $38.29
- AVG Volume (30 Days)
- IBRX 6.3M
- VITL 959.0K
- Earning Date
- IBRX 11-12-2024
- VITL 03-06-2025
- Dividend Yield
- IBRX N/A
- VITL N/A
- EPS Growth
- IBRX N/A
- VITL 151.76
- EPS
- IBRX N/A
- VITL 1.12
- Revenue
- IBRX $7,332,000.00
- VITL $576,129,000.00
- Revenue This Year
- IBRX $2,515.60
- VITL $29.86
- Revenue Next Year
- IBRX $766.19
- VITL $18.56
- P/E Ratio
- IBRX N/A
- VITL $40.05
- Revenue Growth
- IBRX 1218.71
- VITL 29.14
- 52 Week Low
- IBRX $2.28
- VITL $14.16
- 52 Week High
- IBRX $10.53
- VITL $48.41
- Technical
- Relative Strength Index (RSI)
- IBRX 48.30
- VITL 73.92
- Support Level
- IBRX $2.28
- VITL $41.67
- Resistance Level
- IBRX $2.54
- VITL $43.80
- Average True Range (ATR)
- IBRX 0.25
- VITL 1.98
- MACD
- IBRX 0.10
- VITL 0.46
- Stochastic Oscillator
- IBRX 64.71
- VITL 92.21
About IBRX ImmunityBio Inc.
ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: United states and Europe. Key revenue is generated from Europe.
About VITL Vital Farms Inc.
Vital Farms Inc is an ethical food company. The company retails pasture-raised eggs and butter. Its products include Pasture-Raised Eggs and Pasture-Raised Butter & Ghee. The company's purpose is rooted in a commitment to Conscious Capitalism, which prioritizes the long-term benefits of its stakeholders (farmers and suppliers, customers and consumers, communities and the environment, employees, and stockholders).